The aim of this study was to describe the pattern, characteristics, and outcomes of infective endocarditis (IE) in Yemen and compare the results with the findings of a Western university hospital. Patients (pts) with a final diagnosis of IE observed in Al-Thawra Sanaa Cardiac Center were prospectively enrolled in 1-year time period. Clinical and diagnostic findings were compared to clinical and diagnostic data of 50 pts with IE observed at Sapienza University Hospital in Rome, Italy. The mean age was 38 ± 6. Predisposing factors for IE were rheumatic heart disease (RHD) in 34 pts (68%), congenital heart disease in 9 pts (18%), prosthetic valve IE in 4 pts (8%), and previous IE in 3 pts (6%). Transthoracic echocardiography (TTE) was done in 50 pts and transesophageal echocardiography (TEE) in 25. Blood cultures were taken in all pts and were positive in 3 pts (6%) and negative in 47 (94%). TTE was positive in 34/50 pts (68%) and TEE in 20/25 (80%). Compared to Sapienza University pts, Al-Thawra Cardiac Center pts had a younger age (p = 0.003), more predisposing RHD (p = 0.0004), less prosthetic heart valves IE (p = 0.002), and more negative blood cultures (p = 0.0001). IE is still a common disease in Yemen among RHD pts and affects the younger age group. It has severe complications which need early diagnosis and proper management. Echocardiography is of prime diagnostic value in the absence of positive blood cultures. An effort should be made to prevent rheumatic fever and RHD.
BaddourLMWilsonWRBayerAS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation2015; 132(15): 1435–1486.
2.
HabibGLancellottiPAntunesMJ, et al. 2015ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European society of cardiology (ESC). Endorsed by: European association for cardio-thoracic surgery (EACTS), the European association of nuclear medicine (EANM). Eur Heart J2015; 36(44): 3075–3128.
TariqMSiddiquiBKJadoonA, et al. Clinical profile and outcome of infective endocarditis at the Aga Khan University hospital. Int J Collab Res Intern Med Public Health2009; 1(3): 84–99.
5.
KhanNUFarmanMTSialJA, et al. Changing trends of infective endocarditis. J Pak Med Assoc2010; 60(1): 24–27.
6.
AmbrosioniJHernandez-MenesesMTéllezA, et al. The changing epidemiology of infective endocarditis in the twenty-first century. Curr Infect Dis Rep2017; 19(5): 21.
7.
SadakaSMEl-GhazzawyIFHassanenMM, et al. Molecular and serological techniques for the diagnosis of culture negative infective endocarditis in Alexandria Main University Hospital. Egypt Heart J2013; 65(3): 145–152.
8.
LiJSSextonDJMickN, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis2000; 30(4): 633–638.
9.
SiddiquiBKTariqMJadoonA, et al. Impact of prior antibiotic use in culture-negative endocarditis: review of 86 cases from southern Pakistan. Int J Infect Dis2009; 13(5): 606–612.
10.
HabibGBadanoLTribouilloyC, et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur J Echocardiogr2010; 11(2): 202–219.
AlkhawamHSogomonianRZaiemF, et al. Morbidity and mortality of infective endocarditis in a hospital system in New York City serving a diverse urban population. J Investig Med2016; 64(6): 1118–1123.
13.
WatkinsDABeatonAZCarapetisJR, et al. Rheumatic heart disease worldwide: JACC scientific expert panel. J Am Coll Cardiol2018; 72(12): 1397–1416.
14.
KhaledAAAl-NoamiAYAl-AnsiM, et al. Clinical features and outcome of infective endocarditis in Yemeni patients treated with empirical antibiotic therapy. Heart Views2010; 11(1): 2–9.
15.
KoegelenbergCFDoubellAFOrthH, et al. Infective endocarditis in the Western cape province of South Africa: a three-year prospective study. QJM2003; 96(3): 217–225.
16.
ZühlkeLEngelMEKarthikeyanG, et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the global rheumatic heart disease registry (the REMEDY study). Eur Heart J2015; 36(18): 1115–1122a.
17.
BeatonAOkelloERwebemberaJ, et al. Secondary antibiotic prophylaxis for latent rheumatic heart disease. N Engl J Med2022; 386(3): 230–240.
18.
ReményiBWilsonNSteerA, et al. World heart federation criteria for echocardiographic diagnosis of rheumatic heart disease–an evidence-based guideline. Nat Rev Cardiol2012; 9(5): 297–309.
19.
KaneAMirabelMTouréK, et al. Echocardiographic screening for rheumatic heart disease: age matters. Int J Cardiol2013; 168(2): 888–891.
20.
HunterLDMonaghanMLloydG, et al. Screening for rheumatic heart disease: is a paradigm shift required?Echo Res Pract2017; 4(4): R43–R52.
21.
MurdochDRCoreyGRHoenB, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study. Arch Intern Med2009; 169(5): 463–473.
22.
ToddAJLeslieSJMacdougallM, et al. Clinical features remain important for the diagnosis of infective endocarditis in the modern era. QJM2006; 99(1): 23–31.
23.
AfonsoLKottamAReddyV, et al. Echocardiography in infective endocarditis: state of the art. Curr Cardiol Rep2017; 19(12): 127.
24.
SifaouiIOliverLTacherV, et al. Diagnostic performance of transesophageal echocardiography and cardiac computed tomography in infective endocarditis. J Am Soc Echocardiogr2020; 33(12): 1442–1453.
25.
GewitzMHBaltimoreRSTaniLY, et al. Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the american heart association. Circulation2015; 131(20): 1806–18.
26.
GulerAKarabayCYGursoyOM, et al. Clinical and echocardiographic evaluation of mitral valve aneurysms: a retrospective, single center study. Int J Cardiovasc Imaging2014; 30(3): 535–541.
27.
GouldFKDenningDWElliottTS, et al. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the working party of the British society for antimicrobial chemotherapy. J Antimicrob Chemother2012; 67(2): 269–289.
28.
LetaiefABoughzalaEKaabiaN, et al. Epidemiology of infective endocarditis in Tunisia: a 10-year multicenter retrospective study. Int J Infect Dis2007; 11(5): 430–433.
29.
KangDHKimYJKimSH, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med2012; 366(26): 2466–2473.
30.
RevillaALópezJVilacostaI, et al. Clinical and prognostic profile of patients with infective endocarditis who need urgent surgery. Eur Heart J2007; 28(1): 65–71.
31.
JamilMSultanIGleasonTG, et al. Infective endocarditis: trends, surgical outcomes, and controversies. J Thorac Dis2019; 11(11): 4875–4885.
32.
HabibG.Management of infective endocarditis. Heart2006; 92(1): 124–130.
33.
HubersSADeSimoneDCGershBJ, et al. Infective endocarditis: a contemporary review. Mayo Clin Proc2020; 95(5): 982–997.
34.
HollandDJSimosPAYoonJ, et al. Infective endocarditis: a contemporary study of microbiology, echocardiography and associated clinical outcomes at a major tertiary referral centre. Heart Lung Circ2020; 29(6): 840–850.
